PRESS-RELEASE ·Filed Oct 2, 2026
Press release · Activist
Actionable Insight • Neutral
No immediate trading catalyst. Monitor upcoming Phase 3 data readouts for palazestrant (OP-1250) as the primary value driver.
Latest settled — T+5d
OLMA ▼ -10.79% at T+5d
NEUTRAL call -10.79% · α vs SPY -11.21% · entry $8.25 → $7.36
Latest observation: T+14 -9.41% FF3 residual α
T+1d
-4.00%
call -4.00% · α -4.55%
$7.92
settled 21d ago
T+5d
-10.79%
call -10.79% · α -11.21%
$7.36
settled 17d ago
T+20d
Pending
in 4d
T+60d
Pending
in 2mo
Price Chart
Loading chart...
Executive Summary
Olema Oncology granted inducement stock options for 235,950 shares to six new employees at $8.27/share, vesting over four years. This is a routine hiring-related equity grant under Nasdaq Rule 5635(c)(4) with no material financial impact.
Key Facts
- 235,950 shares of common stock subject to inducement stock options granted to six new employees
- Exercise price of $8.27 per share, equal to October 1, 2026 closing price
- Options vest over four years (25% at one year, remainder monthly over three years)
- Granted under 2022 Inducement Plan per Nasdaq Listing Rule 5635(c)(4)
Financial Impact
Routine equity grant — no cash impact; potential dilution of ~0.4% based on ~60M shares outstanding (estimated from prior filings).
dilution
Risk Factors
- Dilution from future equity grants under inducement plan
- Clinical-stage company with no approved products — pipeline risk remains primary
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3374040 |
16 reports for OLMA
25% Hit rate @ T+20 Went positive at some point 1 of 4 best @ T+1▲ +12.65%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 9d ago | SC 13D/A | $7.11 | awaiting T+20 | — | $6.62 (−6.89%) |
Oct 15, 2026 11d ago | 8-K | $6.58 | awaiting T+20 | — | $6.62 (+0.61%) |
Oct 2, 2026 24d ago | Press Release | $8.25 | awaiting T+20 | — | $6.62 (−19.76%) |
Aug 10, 2026 11w ago | 8-K | $10.43 $10.36 | ▼ −0.67% | ▲ +0.39% | $6.62 (−36.53%) |
Aug 10, 2026 11w ago | Press Release | $10.43 $10.36 | ▼ −0.67% | ▲ +0.39% | $6.62 (−36.53%) |
Aug 9, 2026 11w ago | Institutional Cluster | $11.94 $10.99 | ▲ +8.00% | ▲ +7.08% | $6.62 (+44.56%) |
May 26, 2026 21w ago | 8-K | $13.55 $11.46 | ▼ −15.42% | ▼ −13.48% | $6.62 (−51.14%) |
May 26, 2026 21w ago | Press Release | $13.55 $11.46 | ▼ −15.42% | ▼ −13.48% | $6.62 (−51.14%) |
May 21, 2026 22w ago | 8-K | $13.68 $10.19 | ▼ −25.51% | ▼ −24.10% | $6.62 (−51.61%) |
May 21, 2026 22w ago | Press Release | $13.68 $10.19 | ▼ −25.51% | ▼ −24.10% | $6.62 (−51.61%) |
Showing 10 of 16
US Market Status
Market Closed — Opens Tue (16h 1m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers